We have investigated the mechanisms of the anabolic effect of insulin on muscle protein metabolism in healthy volunteers, using stable isotopic tracers of amino acids. Calculations of muscle protein synthesis, breakdown, and amino acid transport were based on data obtained with the leg arteriovenous catheterization and muscle biopsy. Insulin was infused (0.15 mU/min per 100 ml leg) into the femoral artery to increase femoral venous insulin concentration (from 10+2 to 77±9 uU/ml) with minimal systemic perturbations. Tissue concentrations of free essential amino acids decreased (P < 0.05) after insulin. The fractional synthesis rate of muscle protein (precursor-product approach) increased (P < 0.01) after insulin from 0.0401±0.0072 to 0.0677±0.0101%/h. Consistent with this observation, rates of utilization for protein synthesis of intracellular phenylalanine and lysine (arteriovenous balance approach) also increased from 40±8 to 59±8 (P < 0.05) and from 219±21 to 298±37 (P < 0.08) nmol/min per 100 ml leg, respectively. Release from protein breakdown of phenylalanine, leucine, and lysine was not significantly modified by insulin. Local hyperinsulinemia increased (P < 0.05) the rates of inward transport of leucine, lysine, and alanine, from 164±22 to 200±25, from 126±11 to 221±30, and from 403±64 to 595±106 nmol/min per 100 ml leg, respectively. Transport of phenylalanine did not change significantly. We conclude that insulin promoted muscle anabolism, primarily by stimulating protein synthesis independently of any effect on transmembrane transport. (J. Clin. Invest. 1995. 95:811-819.)
Introduction
There is considerable evidence that insulin plays a major role in the regulation of muscle protein metabolism, but its mechanisms of action are not fully understood (1, 2 Receivedfor publication 26 April 1994 and in revisedform 7 October 1994.
The University of Texas Medical Branch; and the IShriners Burns hormone can potentially exert its effect by increasing protein synthesis and/or inhibiting proteolysis. An insulin stimulatory effect on muscle protein synthesis has been clearly shown in different experimental conditions (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) . Insulin also decreases the proteolytic activity of lysosomes (11) , but recent evidence suggests that the bulk of muscle protein is degraded by a different pathway that is not under insulin control (12) (13) (14) . Further, the processes of synthesis and breakdown can be directly affected by the rates of transmembrane transport of amino acids which, in turn, could be under hormonal control. Insulin has been shown to influence the activity of at least four distinct transport systems of amino acids, named systems A, ASC, Nm, and xc (16) (17) (18) (19) (20) (21) . However, evidence indicates that the insulin effects on amino acid transport are minor for most of the system studied (19, 21) , except possibly for system Nm (18) .
Despite the evidence that insulin may affect all possible steps of muscle protein metabolism, the demonstration of such effects in vivo in humans has been difficult for both physiological and technical reasons. When insulin was infused, systemically hypoaminoacidemia developed (22, 23) because of the hormone action on extramuscular tissues (24). As a consequence, the availability of plasma amino acids decreased, counteracting the anabolic insulin effect on muscle (24, 25) . Furthermore, the rates of muscle protein synthesis and breakdown have been measured in human limbs (leg or forearm) as rates of amino acid appearance into and disappearance from plasma (26, 27) . This approach underestimates the actual intracellular values of protein synthesis and breakdown, because a fraction of the intracellular amino acids resulting from protein breakdown is directly reincorporated into protein without entering plasma. The extent of such underestimation depends on the isotopic equilibration between extracellular and intracellular free amino acid pools, which is primarily determined by the transmembrane transport kinetics of each individual amino acid (28, 29) .
In this study we have evaluated the insulin effects on amino acid and protein metabolism in the human skeletal muscle using a new method (28, 29) , that combines the traditional arterialvenous balance technique with the biopsy of the vastus lateralis muscle. Intracellular amino acid and protein kinetics were directly assessed, whereas transmembrane amino acid transport was separately determined as the rate of amino acid exchange between the intracellular and vascular compartments. To assess the validity of the model-derived values of muscle protein synthesis (and those other model-derived values based on the same assumptions), we have also used the traditional precursor-product technique (30) . Insulin was directly infused into the femoral artery to raise femoral venous insulin concentration to a high physiological level, without decreasing amino acid delivery to the leg. height was 170±3, and the body mass index was 25±1 kg/cm2. The leg volume, estimated using an anthropometric approach (31), was 10,327±657 ml. All subjects gave informed, written consent before participating in the study, which was approved by the Institutional Re- To measure leg blood flow in the basal state, at 165 min a primedcontinuous infusion of indocyanine green dye (IR = 0.5 mg/min; PD=5 mg) was started into the femoral artery and maintained until 240 min (33, 34) . Between 180 and 240 min blood samples were taken every 20 min from the femoral vein, an arterialized wrist vein, and the femoral artery. To allow sampling from the femoral artery, the dye infusion was stopped for < 10 s and then quickly resumed. Arterial samples were always taken after samples from the femoral and wrist veins to avoid interference with blood flow measurement. At 240 min (end of basal period) the second muscle biopsy was taken. After the basal period, insulin was infused directly into the femoral artery at 0.15 mU/min per 100 ml leg for 3 h. Blood glucose was maintained at the basal euglycemic levels by means of appropriate 5% dextrose infusion. Between 360 and 420 min the measurement of leg blood flow was repeated and blood samples were taken as described for the basal period. At 420 min, before stopping tracer and insulin infusions, the third muscle biopsy was taken from the vastus lateralis muscle of the right leg.
Analysis. Blood samples from the femoral artery and vein for determination of amino acid enrichment and concentration were immediately precipitated in preweighed tubes containing 15% sulfosalicylic acid. Simultaneously, a known amount of an internal standard mixture (100 1Al/ml blood) was added to the tube and thoroughly mixed. The composi- To determine the enrichment of the infused tracers and of the internal standards of free phenylalanine, leucine, lysine, and alanine in the whole blood, the nitrogen-acetyl-n -propyl esters were prepared as described in earlier studies (28, 29, 35) . Blood samples from the femoral and arterialized wrist veins were collected to measure indocyanine green concentration in serum, as described (34) . Leg plasma flow was calculated from steady state values of dye concentration in the femoral and arterialized wrist veins as referenced (34) . Leg homogenized, centrifuged, and the supernatant collected. This procedure was repeated twice more. Then, the pooled supernatant (-1.5 ml) was processed separately to produce the nitrogen-acetyl-n-propyl derivatives of intracellular amino acids (29, 35). The pellet was washed once with water and three times with absolute ethanol, and placed overnight in 80°C oven to evaporate the ethanol. Total water content in muscle was obtained from the difference between weights of wet and dried sample. Lipid content was found negligible. The weight of the dried pellet was recorded as muscle protein weight. The precipitated proteins were then hydrolyzed at 110°C for 36 h with 6 N constant boiling HCL. The protein hydrolysate was then passed through columns of acid-washed celite to remove carbon particles. The 4C ] phenylalanine was added to the sample to identify the pher anine fraction because conventional detection (i.e., fluorometric c tor) requires derivatization, which would add other carbons that v also contribute to the CO2 after combustion. For the same reasi carbon-free buffer system was required. Purity of the phenylal fraction was verified using a different HPLC system with fluoron detector (LKB Instruments Inc.). The phenylalanine peak was separated from other amino acids, i.e., tyrosine. Furthermore, the sine peak was always < 2% of the phenylalanine peak, The abili isolate pure phenylalanine was an advantage compared to using lei as the tracer, because complete separation of leucine and isoleucing be a problem. The samples containing pure phenylalanine were i under nitrogen and placed in tin containers and combusted usi carbon/nitrogen analyzer (Nitrogen Analyzer 1500; Carlo Erba In ments/Fisons, Serono, Italy). The resulting CO2 gas was automati injected into an isotope-ratio mass-spectrometer (VG Isogas; VG In ments/Fisons Instruments, Middlewich, United Kingdom) for dete nation of the '3C/'2C isotope ratio in protein-bound phenylalanine
We have evaluated the possibility of contamination of the mi protein precipitate by trapped free labeled phenylalanine. Radiolat L-[U-'4C]phenylalanine (Sigma Chemical Co., St. Louis, MO) solved in 0.9% saline was added to three muscle-biopsy samples tained in normal volunteers. The samples were then deproteinized mogenized, and washed as described above (i.e., three times with trichloroacetic acid, one time with water, and three times with absl ethanol). The radioactivity was measured in the supernatant obta in the progressive washes using a liquid scintillation counter (] Wallac, Gaithersburg, MD). The total amount of radioactivity adde each sample was recovered in the first three washes, whereas in fluid obtained from the further four washed, no radioactivity above background was detected. These results indicate that the purified mu protein was not contaminated by any free-labeled phenylalanine.
The isotopic enrichment of free amino acids in blood and mu samples were determined by gas-chromatography mass-spectromr (Model 5985; Hewlett-Packard Co., Palo Alto, CA) by chemical ion tion and selected ion monitoring (28, 29, 35) . Data were expresse tracer/tracee ratio, with correction for the contribution of isotopol of small weight to the apparent enrichment of isotopomers with a gre mass (28, 29, 35) . Enrichment of L[ring-'3C6jphenylalanine was fur corrected using a factor of 0.93 to account for an overestimatioi enrichment, due to the different isotopomer distribution of the tr and the naturally occurring phenylalanine (29, 35) .
Concentrations (C) (nmol/ml) of free amino acids in blood total muscle water was calculated as follows (28, 29, 35) :
where Qls (nmol) is the amount of internal standard added to the sam V is the volume of blood or muscle water, and Els is the inter standard tracer/tracee ratio in blood or muscle water as measured gas-chromatography mass-spectrometry. Measured values of enrichn and concentrations relative to total tissue water were corrected accord to references 29 and 32 to obtain intracellular values. This correct required the knowledge of both the amino acid concentration and enri ment in the interstitial fluid, and the proportion of intracellular extracellular water in muscle. We have assumed that amino acid enri ment and concentrations in the interstitial fluid equaled blood value the femoral vein (32) . We have measured the intracellular and extra( lular water volumes in the muscle tissue of three subjects using chloride method (32) . The ratio between intracellular and extracell spaces averaged 0.16 (SEM = 0.015). This value was in agreem with other laboratories (32) and was applied to all subjects.
Calculations. Muscle FSR in the basal period and during insu infusion was calculated by dividing the increment in enrichment the product, i.e., protein-bound L-[ring "3C6jphenylalanine tracer/tra ratio, by the enrichment of the precursor, i.e., free intracellular L-[r '3C6phenylalanine tracer/tracee ratio (29, 30 The kinetics of free amino acids in leg muscle have been described by the model shown in Fig. 1 (28, 29) . Amino acids enter and leave the leg via femoral artery (Fin) and femoral vein (Fu,), respectively. Free amino acid pools in arterial (A) and venous (V) blood, and in muscle (M) are connected by arrows indicating the unidirectional amino acid flow between each compartment. FM.A and FvM refer to the rates of net amino acid movement from artery to muscle and from muscle to femoral vein, i.e., inward and outward transmembrane transport, respectively. FMO for the essential amino acids phenylalanine, leucine, and lysine defines the rate of intracellular amino acid appearance from protein breakdown. In the case of alanine, FMO represents the sum of release from protein breakdown and de novo synthesis from pyruvate. Since phenylalanine and lysine are not oxidized in muscle (38) , FOM for these amino acids refers to the rate of utilization for protein synthesis. In the case of leucine, FOM represents utilization for protein synthesis plus oxidation. Each kinetic parameter is defined as follows (see references 28 Tables  I and II average values of free amino acid concentrations and enrichments in the femoral artery and vein and in muscle are reported. After local insulin infusion, arterial concentrations of phenylalanine, lysine, and alanine did not change significantly, whereas leucine slightly, but significantly, decreased. Intracellular concentrations of all essential amino acids decreased after insulin infusion, phenylalanine by -18%, leucine by -35%, and lysine by -28%. As a consequence, the ratio between intracellular and arterial concentrations of all essential amino acids, expression of transmembrane gradient, decreased. During insulin infusion, there was a tendency of intracellular alanine concentration to increase, but this was not statistically significant. However, the increment of the cell/artery gradient for alanine concentration, was significant. After insulin infusion, the arterial enrichment of amino acids increased, indicating a decrease of the whole-body amino acid turnover. Intracellular 814 G. Biolo . These data demonstrated that the metabolism of these two tracers of phenylalanine is similar both in the skeletal muscle and at the whole body level. Fig. 4 shows the effects of the intraarterial insulin infusion on the fractional synthesis rate of muscle protein. The increment (per hour) of the protein-bound L[ring-'3C6phenylalanine enrichment (AEp) was greater (P < 0.05) during insulin infusion (1.15 * 10-41.58 * 10-5) than in the basal period (6.10 -10-51.05* 10-) . Enrichment of the free intracellular phenylalanine (EM) did not change significantly during the study (Table II) . Consequently, the fractional synthesis rate of muscle protein was -65% higher (P = 0.02) during insulin infusion (0.0677±0.0101%/h) than in the basal period (0.0401 ±0.0072%/h) (Fig. 4) . Table Il from proteolysis of the essential amino acids phenylalanine, leucine, and lysine did not change after insulin infusion. In contrast, alanine appearance (FMO) tended to increase after insulin infusion, indicating an acceleration of the rate of alanine de novo synthesis. In agreement with data obtained with the direct incorporation technique, the model-derived value of intracellular phenylalanine disappearance (FO m) to protein synthesis significantly increased after insulin infusion. Also, lysine disappearance (FOM) to protein synthesis tended to increase after insulin infusion (P < 0.08). Fig. 5 shows the values of inward amino acid transport (FM.A) normalized by the rate of arterial amino acid delivery (F.). This figure accounts for the insulinmediated variations of leg blood flow and of systemic amino acid concentrations, and expresses the fraction of arterial amino acids taken up by the transmembrane transport systems in the leg muscle. Insulin slightly increased the fractional transport of alanine and lysine, without affecting leucine and phenylalanine.
Discussion
In this study we found that the primary effect of local physiologic hyperinsulinemia on skeletal muscle protein metabolism was to increase the rate of protein synthesis, whereas the rate of protein breakdown did not change significantly. Transmembrane amino acid transport was not uniformly affected by insulin. The rate of alanine and lysine transport increased more than that of leucine, whereas transport of phenylalanine did not change significantly. Further, amino acid transport was not sufficiently accelerated to balance the increased utilization of intracellular amino acids for protein synthesis. As a consequence, the intramuscular concentrations of the essential amino acids decreased. These results indicate that insulin promotes net protein deposition in muscle by directly increasing the rate of protein synthesis. The regulation of transmembrane amino acid transport does not appear to be a primary mediator of the insulin anabolic action on muscle.
A number of studies, performed at the molecular level, have demonstrated insulin's ability to promote several steps of the process of protein synthesis in skeletal muscle ( 10) . In contrast, when insulin effects on muscle protein synthesis have been evaluated in vivo, the results were less convincing, having depended on the method used and on the experimental conditions. A frequent complication is that systemic insulin infusion decreases plasma amino acid concentrations (22, 23) by acting at sites different than muscle (24). Thus, it is possible that, in some studies, a stimulatory effect on protein synthesis in vivo was obscured by the insulin-induced hypoaminoacidemia (24, 25 (26, 27) . Phenylalanine and lysine Rd increased significantly after insulin infusion, from 22±5 to 35±5 and from 73±7 to 129±14 pmol/min per 100 ml leg, respectively.
The combination of the arteriovenous balance technique with the muscle biopsy allowed us to measure, directly, the rate of intracellular amino acid appearance from protein breakdown in muscle. We have used stable isotopic tracers of three different essential amino acids: phenylalanine, leucine, and lysine. The results obtained with all the three amino acids did not show any significant modification of protein breakdown by insulin infusion. This may represent a type 2 statistical error. However, the lack of a significant insulin effect on muscle protein breakdown we observed in vivo is consistent with expectations from in vitro findings (14) . It has been shown that, during adequate amino acid supply, the most important degradative system in muscle is an ATP-independent system that requires the presence of a specialized protein, termed ubiquitin (13, 14, 41) . This system is not sensitive to insulin (14) . Insulin apparently plays a role only in the regulation of the lysosome activity (14) . These intracellular organelles are not involved in the myofibrillar protein degradation in normal conditions, but only in the presence of low insulin levels or decreased amino acid availability (12) (13) (14) . This was not the case in our study, where amino acid delivery to leg muscle (Fin) did not decrease during local hyperinsulinemia.
In contrast to our findings, other investigators using different experimental designs, have shown that insulin decreased the rate of appearance (Ra) of essential amino acids both across the forearm (26, 42) and the leg (43), thus concluding that insulin suppressed muscle protein breakdown in vivo. In our study, amino acid Ra across the leg as calculated according to reference 26, tended to decrease after insulin infusion for phenylalanine and leucine (from 39±6 to 28±3 (P = 0.10) and from 96±+11 to 80±8 (P = 0.06) /.Lmol/min per 100 ml, respectively). For lysine, however, there was no change (from 104±5 to 108±11 4Lmol/min per 100 ml leg). These data, however, do not necessarily reflect a decreased rate of protein breakdown. Amino acids appearing intracellularly from protein breakdown can either be transported out of the cell (FvM) and appear into the bloodstream, or be reutilized for protein synthesis (or oxidation in the case of leucine) (FOm). Thus, in our study, the apparent discrepancies between the traditional calculation of plasma amino acid Ra 23) indicating that relatively more phenylalanine appearing from protein breakdown was directed to protein synthesis than to outward transport. For lysine, however, no change of the ratio FVM/FoM was observed (from 0.76±0.10 to 0.70±0.12). These results show that the traditional measurement of amino acid Ra in plasma is a poor index of protein breakdown, since they are strongly influenced by the relative rates of outward transport and protein synthesis (or oxidation in the case of leucine). In addition, it has been recently shown that insulin infusion decreased phenylalanine and tyrosine Ra across the arm without affecting 3-methylhistidine release from muscle, an index of myofibrillar protein degradation that cannot be reutilized for protein synthesis (44) . These results may be interpreted as a selective insulin effect on the nonmyofibrillar protein degradation, or, alternatively, they may further demonstrate the unreliability of the amino acid Ra in plasma as markers of muscle protein breakdown.
In our study, after insulin infusion, inward transmembrane transport of alanine, lysine, and leucine significantly increased, whereas transport of phenylalanine did not change. Acceleration of alanine and lysine transport (approximately +48% and +75%, respectively) was more pronounced than that of leucine (approximately +22%). The same results were obtained also after normalization of inward transport per unit of amino acid concentration in the artery. This normalization accounts for the slight changes of systemic amino acid concentrations after insulin. The insulin effect on alanine transport was expected on the basis of a large number of studies. Alanine is a major substrate of system A, a sodium-dependent system that maintains steep transmembrane gradients of amino acid concentrations. This system has been shown to be regulated by insulin both in vitro and in vivo (15) (16) (17) (19) (20) (21) . Lysine is a cationic amino acid that is transported by the sodium independent system y+. Its activity is sodium independent, but is strongly influenced by the electrochemical potential of cell membrane (20, 45 ) . Insulin has been shown to induce hyperpolarization in the skeletal muscle cells by directly activating the Na+-K+ -ATPase pump (46). Thus, acceleration of lysine transport may be secondary to the primary insulin effect on the electrochemical transmembrane gradient. The insulin effect on leucine transport is unexpected on the basis of in vitro studies. The branched-chain (leucine, valine, and isoleucine) and the aromatic (phenylalanine and tyrosine) amino acids are preferably transported through system L (15-17, 19, 20) . This sodium-independent system is unable to generate high transmembrane gradients for its substrates ( 15-17, 19, 20) . It has been shown that the kinetic characteristics of system L are not influenced by insulin (15-17, 19, 20) . However, the postinsulin increase in leg blood flow may increase local amino acid delivery to muscle and, secondarily, amino acid transport. To exclude the effect of variations of blood flow, we have normalized inward amino acid transport per unit amino acid delivery. This figure is independent of blood flow and arterial amino acid concentration. After this normalization (Fig. 5) , we found that the fractional transport of alanine and lysine was still slightly increased after insulin by -20 and -35%, respectively, whereas transport of leucine and phenylalanine did not change. Thus, it is likely that the insulin action on leucine transport was not direct but mediated by an increase in blood flow.
After insulin infusion, the intracellular alanine production (FMo) tended to increase in muscle (Table E) . This change was completely accounted for by an acceleration of alanine de novo synthesis from pyruvate, because the rate of amino acid appearance from protein breakdown did not increase after insulin (Table III) . In a variety of physiological circumstances, alanine formation is a function of the availability of pyruvate rather than of the rate of protein breakdown (47, 48) . Thus, an increase of alanine synthesis would be expected in our study because of the insulin-mediated increase of glucose uptake and intracellular production of pyruvate in muscle. Despite the increased intracellular alanine formation, alanine release from muscle did not increase (Table III) . This is explained by the fact that the rate of inward alanine transport also increased. As a consequence, the intracellular concentration of alanine increased after insulin infusion ( Table I) .
The values of intracellular amino acid enrichments used in the calculations have been obtained from the values relative to the total tissue water corrected for the water distribution between the intracellular and extracellular spaces (29, 32 
